Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
XRF ScientificASX:XRF +1.19%98 EV-to-EBITDA is 13.53 as of Jul. 20, 2026, which is 30% above its 10-year median of 10.37. GuruFocus rates ASX:XRF with a GF Score™ of 98/100 and a GF Value™ of A$1.66 (Fairly Valued). The stock has 1 warning sign investors should review. Among 476 Conglomerates companies, XRF Scientific ranks worse than 71.64% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, XRF Scientific's enterprise value is A$230.65 Mil.
XRF Scientific's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$17.05 Mil. Therefore, XRF Scientific's EV-to-EBITDA for today is 13.53.
The historical rank and industry rank for XRF Scientific's EV-to-EBITDA or its related term are showing as below:
ASX:XRF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.48 Med: 10.37 Max: 19.09
Current: 13.53
During the past 13 years, the highest EV-to-EBITDA of XRF Scientific was 19.09. The lowest was 4.48. And the median was 10.37.
ASX:XRF's EV-to-EBITDA is ranked worse than 71.64% of 476
companies
in the Conglomerates industry
Industry Median: 8.985
vs ASX:XRF: 13.53
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
XRF Scientific (ASX:XRF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
XRF Scientific's PE Ratio (TTM) for today is calculated as:
XRF Scientific's share price for today is A$1.70.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. XRF Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.075.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for XRF Scientific's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, XRF Scientific's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XRF Scientific EV-to-EBITDA vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, XRF Scientific's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where XRF Scientific's EV-to-EBITDA falls into.
XRF Scientific's current Enterprise Value is A$230.65 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. XRF Scientific's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$17.05 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XRF Scientific (ASX:XRF) has a EV-to-EBITDA of 13.53 as of Jul. 20, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on XRF Scientific. This is 30% above median its historical median of 10.37. Over the past decade, XRF Scientific's EV-to-EBITDA has ranged from 4.48 to 19.09. According to the industry distribution chart, XRF Scientific ranks #341 out of 476 companies in the Conglomerates industry, placing it in the top 71.6%.
Is XRF Scientific's EV-to-EBITDA too high?
XRF Scientific's current EV-to-EBITDA of 13.53 is 30% above median its 10-year median of 10.37. Over the past 10 years, this metric has ranged from a low of 4.48 to a high of 19.09. The Conglomerates industry median EV-to-EBITDA is 8.99. XRF Scientific's value of 13.53 is 50.6% above this industry median. Based on the distribution chart, XRF Scientific ranks #341 out of 476 companies in the Conglomerates industry, which is below the industry midpoint. Overall, XRF Scientific has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does XRF Scientific's EV-to-EBITDA compare to HON and MMM?
According to the Conglomerates industry distribution chart, XRF Scientific ranks #341 out of 476 companies for EV-to-EBITDA. This places XRF Scientific in the lower half of its industry. The industry median EV-to-EBITDA is 8.99. XRF Scientific's value of 13.53 is 50.6% above this benchmark. Historically, XRF Scientific's own EV-to-EBITDA has ranged from 4.48 to 19.09 over the past decade. While the company's 10-year median is 10.37 vs. the industry median of 8.99, XRF Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Conglomerates company?
The median EV-to-EBITDA among Conglomerates companies is 8.99, based on 476 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. XRF Scientific's current EV-to-EBITDA of 13.53 is 50.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on XRF Scientific. For the Conglomerates industry, the median EV-to-EBITDA is 8.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. XRF Scientific's current EV-to-EBITDA is 13.53, which is 30% above median its own 10-year median of 10.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XRF Scientific stock overvalued right now?
Based on GuruFocus' analysis, XRF Scientific (ASX:XRF) is currently considered Fairly Valued. The stock's GF Value™ is A$1.66, compared to a current price of A$1.70 — trading 2.4% above its estimated fair value. The current EV-to-EBITDA is 13.53, which is 30% above median its 10-year median of 10.37 and 50.6% above the Conglomerates industry median of 8.99. XRF Scientific's overall GF Score™ is 98/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For XRF Scientific (ASX:XRF), the current EV-to-EBITDA is 13.53 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is XRF Scientific (ASX:XRF) Overvalued in 2026?
Based on GuruFocus' analysis, XRF Scientific stock appears to be overvalued.
The current stock price of A$1.70 is trading 2.4% above its estimated GF Value™ of A$1.66.
GuruFocus considers XRF Scientific to be Fairly Valued.
Key valuation signals for ASX:XRF:
EV-to-EBITDA: 13.53 (30% above median its 10-year median of 10.37)
GF Value™: A$1.66 vs. price of A$1.70 (2.4% above fair value)
Industry Position: 50.6% above the Conglomerates median (#341 of 476)
No single metric tells the full story. See the ASX:XRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
98GF Score
Get the complete analysis for ASX:XRF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:XRF has been successfully added to your 
